Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Current Deferred Revenue (2018 - 2026)

Argan's Current Deferred Revenue history spans 9 years, with the latest figure at $514.0 million for Q1 2026.

  • On a quarterly basis, Current Deferred Revenue rose 71.76% to $514.0 million in Q1 2026 year-over-year; TTM through Jan 2026 was $514.0 million, a 71.76% increase, with the full-year FY2026 number at $514.0 million, up 71.76% from a year prior.
  • Current Deferred Revenue hit $514.0 million in Q1 2026 for Argan, up from $451.9 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for AGX hit a ceiling of $514.0 million in Q1 2026 and a floor of $49.0 million in Q4 2022.
  • Historically, Current Deferred Revenue has averaged $211.7 million across 5 years, with a median of $181.1 million in 2024.
  • Biggest five-year swings in Current Deferred Revenue: tumbled 72.21% in 2022 and later surged 218.51% in 2023.
  • Tracing AGX's Current Deferred Revenue over 5 years: stood at $49.0 million in 2022, then surged by 218.51% to $156.2 million in 2023, then surged by 73.33% to $270.7 million in 2024, then skyrocketed by 66.95% to $451.9 million in 2025, then grew by 13.73% to $514.0 million in 2026.
  • Business Quant data shows Current Deferred Revenue for AGX at $514.0 million in Q1 2026, $451.9 million in Q4 2025, and $316.8 million in Q3 2025.